TomWinnifrith.com

While many base metals stocks have pushed ahead sharply during the past few weeks on the back of hopes of a rebound in Chinese demand, AIM and TSX listed EMED (EMED) has made steady gains on the basis that its agonisingly protracted attempts to restart production and it Spanish Rio Tinto copper mine will finally get the requisite regulatory clearance. The most recent quarterly statement (on January 16th) indicated that all was on track and that has seen the shares move ahead to 12.75p, valuing the company at £164 million. However, I still expect the shares to treble from here on a two year view.